<<>>>
TitleUrlVersionPublisher
Monofilament Testshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120420230721NCQA PHEMUR
C2S Opioidshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.4220160909SAMHSA Steward
FGFR3 Gene Interpretation Positive NCIhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.13120240216CancerLinQ Steward
Methemoglobinemia (Disorders) (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.210720230125CSTE Steward
Housing Adequacyhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.114220210927HL7 Patient Care WG Steward
Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154620230125CSTE Steward
ECOG Performance Statushttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.16220150909American Society of Clinical Oncology Steward
Material Hardship Screening Assessments Questionshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.16820230719The Gravity Project Steward
Palpation of Abdomenhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.3.104320190108Oncology Nursing Society Steward
Hypertension Stagehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.57120210912HL7 Patient Care WG Steward
HER2 Positivehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.3120230919CancerLinQ Steward
SCLC and rarer lung cancer histologyhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.19720240404CancerLinQ Steward
Dengue Virus Infection (Organism or Substance in Lab Results)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.52820200516CSTE Steward
ActRelationshipSubsethttp://terminology.hl7.org/ValueSet/v3-ActRelationshipSubset2.0.0
Genital herpes (Disorders) (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.177920220602CSTE Steward
Cirrhosis_Groupinghttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.37520230929B.well Connected Health Steward
Provider Typeshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.5320220511Brigham and Women’s Hospital Steward
Myocardial infarction I10http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.26820230405Optum Steward
Medication Supporting Immunosuppressive Medication HCPCShttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.8320220315CMS DRLS Steward
One High Risk Medication Not Orderedhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.1720180510Change Healthcare Steward
Bilateral Oophorectomyhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102420210909NCQA PHEMUR
Phantom Painhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.66920210915HL7 Patient Care WG Steward
Hepatocellular Carcinomahttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.9120190308AGA Steward
Acute or Evolving MIhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.109820180809Lantana EH Steward
Rehabilitation Value Sethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1195.33520190130NJII Steward
Pertussis (Test Panels for Bordetella pertussis Toxin Antibody)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.64620190608CSTE Steward
Trifluoperazinehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113920210915NCQA PHEMUR
C. diff infection (Tests for C diff by Culture and Identification Method)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.149520220118CSTE Steward
Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.146820240123CSTE Steward
Cervical Precancer Disordershttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.22820210803MITRE Steward
<<>>>663664665666667<<>>>